Rarity Bioscience

🚀 We are thrilled to welcome Nick Roelofs as our Strategic Business Advisor! Nicolas brings over 40 years of leadership in the life sciences tools and diagnostics industry, having shaped the strategic direction of companies like Agilent Technologies and Bio-Rad Laboratories. He is widely recognized for his strategic vision and operational excellence, with a passion for bringing new technologies to market and helping companies transition from start-up to scale-up. “Having Nick onboard as an advisor is fantastic. This is not the first time Nick is working with padlock-technologies and his commercial experience from Halo Genomics AB and Olink Proteomics are particularly relevant in crafting and refining our commercial and funding strategies“ Linus Bosaeus, CEO Rarity Bioscience Please join us in welcoming Nick to the team! 🙌 #RarityBioscience #superRCA #CareerDevelopment #newhiring #welcometotheteam #cancerdiagnosis Read more about Nicolas joining Rarity here: https://lnkd.in/d9JYWdM9

Thank you The ICCS International Clinical Cytometry Society for a great 2024 annual meeting! The meeting featured many great talks around Minimal Residual Disease including both phenotypic and molecular approaches. A very popular and appreciated session was the in booth talk by Steve Kussick with the inspiring title "Collaboration in Pursuit of High-Sensitivity Molecular MRD Detection", featuring Rarity superRCA assay data from cKIT, NPM1, IDH1/2. And as always, the poster sessions gives you a glimps on what is happening in the field. If you missed the meeting, you can find the superRCA poster presented by PhD Lei Chen #125 here: https://lnkd.in/dw8JB5aF Until next year, Go with the Flow – Add Molecular! #ICCS2024 #MRD #MinimalResidualDisease #superRCA #GoWithTheFlowAddMolecular

The Rarity Bioscience team would like to extend our heartfelt gratitude to all the ESCCA 2024 attendees who visited our booth, posters, or attended the "Meet the Expert" talk by Ann-Sofi Johansson. A big thanks to the ESCCA president, Francesco Buccisano, and the committee for organizing a program filled with excellent talks from international experts. Did you miss the poster presentations during ESCCA? Here are three excellent posters featuring superRCA data: https://lnkd.in/d7h4bJPC 📃 HEM-46: Ultra-sensitive molecular MRD by flow cytometry using superRCA mutation assay for NPM1 positive AML patients 📃 HEM-51: NRAS, WT1, NPM1 and IDH mutation detection for molecular MRD-assessment using Flow Cytometry in pediatric AML 📃 HEM-71: Use of the new superRCA mutation assay for molecular MRD monitoring using flow cytometry in pediatric AML #MRD #mutation #GoWithTheFlowAddMolecular #superRCA

We are excited to present the latest innovation from our research collaboration with Beckman Coulter Life Sciences on how to expand the capabilities of flow cytometry by enabling molecular analysis using the superRCA assays. Join us at The ICCS International Clinical Cytometry Society October 6-8 in Seattle and see a special presentation at Beckman Coulter Life Sciences booth #200 by Steve Kussick and Lei Chen. 🎤 Dr. Steve Kussick, Director of Flow Cytometry, Phenopath, Seattle “Collaboration in Pursuit of High-Sensitivity Molecular MRD Detection” 🗓️ October 7, 09:45-10:15 a.m. ET See also: 📃 Poster #125: Ultra-sensitive molecular MRD on flow cytometry using superRCA mutation assay 🗓️ October 7, 16.00 ET #FlowICCS24 #MRD #mutation #GoWithTheFlowAddMolecular #superRCA

We are excited to present the latest innovation from our research collaboration with Beckman Coulter Life Sciences on how to expand the capabilities of flow cytometry by enabling molecular analysis using the superRCA assays. Join us at The ICCS International Clinical Cytometry Society October 6-8 in Seattle and see a special presentation at Beckman Coulter Life Sciences booth #200 by Steve Kussick and Lei Chen. 🎤 Dr. Steve Kussick, Director of Flow Cytometry, Phenopath, Seattle “Collaboration in Pursuit of High-Sensitivity Molecular MRD Detection” 🗓️ October 7, 09:45-10:15 a.m. ET See also: 📃 Poster #125: Ultra-sensitive molecular MRD on flow cytometry using superRCA mutation assay 🗓️ October 7, 16.00 ET #FlowICCS24 #MRD #mutation #GoWithTheFlowAddMolecular #superRCA

We are excited to present the latest innovation from our research collaboration with Beckman Coulter Life Sciences on how to expand the capabilities of flow cytometry by enabling molecular analysis using the superRCA assays. Join us at The ICCS International Clinical Cytometry Society October 6-8 in Seattle and see a special presentation at Beckman Coulter Life Sciences booth #200 by Steve Kussick and Lei Chen. 🎤 Dr. Steve Kussick, Director of Flow Cytometry, Phenopath, Seattle “Collaboration in Pursuit of High-Sensitivity Molecular MRD Detection” 🗓️ October 7, 09:45-10:15 a.m. ET See also: 📃 Poster #125: Ultra-sensitive molecular MRD on flow cytometry using superRCA mutation assay 🗓️ October 7, 16.00 ET #FlowICCS24 #MRD #mutation #GoWithTheFlowAddMolecular #superRCA

Breast Cancer 🎀 The Pink Ribbon   Join us in raising awareness and supporting the fight against breast cancer. The Pink Ribbon campaign runs throughout October, with the goal of raising funds for Swedish cancer research. Breast cancer is the most common cancer among women worldwide, with 25-30% of patients experiencing a relapse. Although advancements in early detection and treatment have significantly improved survival rates, much work remains in research, prevention, and support for those affected. The Rarity Bioscience team joined forces with Cancerfonden for the 2024 Pink Ribbon, which features a red thread representing the blood flowing within us that can suddenly break. Yet, the red thread continues, symbolizing that life can go on thanks to research. #tillsammansmotcancer #RarityBioscince #MRD #breastcancer #BreastCancerAwareness

Go with the flow- Add Molecular! Great things happen when leaders in their fields meet, see such results being presented at the ESCCA conference in the 'meet the expert session' hosted by Beckman Coulter Life Sciences where Ann-Sofi Johansson is presenting on molecular mutation detection using flow cytometry. #MRD #mutation #superRCA #RarityBioscince

The first day at the ESCCA 2024 was a blast with great interactions and interest in the #superRCA assays and the ability to add molecular analysis to flow cytometry. If you want to know more about our assay, you can visit our booth or read our posters: 📃 HEM-46: Ultra-sensitive molecular MRD by flow cytometry using superRCA mutation assay for NPM1 positive AML patients 📃 HEM-51: NRAS, WT1, NPM1 and IDH mutation detection for molecular MRD-assessment using Flow Cytometry in pediatric AML 📃 HEM-71: Use of the new superRCA mutation assay for molecular MRD monitoring using flow cytometry in pediatric AML #GoWithTheFlowAddMolecular #MRD #NPM1 #superRCA #ESCCA2024 #AML

Go with the flow- Add Molecular! Great things happen when leaders in their fields meet, see such results being presented at the ESCCA conference in the 'meet the expert session' hosted by Beckman Coulter Life Sciences where Ann-Sofi Johansson is presenting on molecular mutation detection using flow cytometry. #MRD #mutation #superRCA #RarityBioscince